Literature DB >> 21233510

Hospital epidemiology and infection control in acute-care settings.

Emily R M Sydnor1, Trish M Perl.   

Abstract

Health care-associated infections (HAIs) have become more common as medical care has grown more complex and patients have become more complicated. HAIs are associated with significant morbidity, mortality, and cost. Growing rates of HAIs alongside evidence suggesting that active surveillance and infection control practices can prevent HAIs led to the development of hospital epidemiology and infection control programs. The role for infection control programs has grown and continues to grow as rates of antimicrobial resistance rise and HAIs lead to increasing risks to patients and expanding health care costs. In this review, we summarize the history of the development of hospital epidemiology and infection control, common HAIs and the pathogens causing them, and the structure and role of a hospital epidemiology and infection control program.

Entities:  

Mesh:

Year:  2011        PMID: 21233510      PMCID: PMC3021207          DOI: 10.1128/CMR.00027-10

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  349 in total

1.  Refinements of environmental assessment during an outbreak investigation of invasive aspergillosis in a leukemia and bone marrow transplant unit.

Authors:  C L Thio; D Smith; W G Merz; A J Streifel; G Bova; L Gay; C B Miller; T M Perl
Journal:  Infect Control Hosp Epidemiol       Date:  2000-01       Impact factor: 3.254

2.  The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals.

Authors:  R W Haley; D H Culver; J W White; W M Morgan; T G Emori; V P Munn; T M Hooton
Journal:  Am J Epidemiol       Date:  1985-02       Impact factor: 4.897

3.  Accidental hepatitis-B-surface-antigen-positive inoculations. Use of e antigen to estimate infectivity.

Authors:  B G Werner; G F Grady
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

4.  Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia.

Authors:  J M Garbutt; M Ventrapragada; B Littenberg; L M Mundy
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

5.  Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

Authors:  K A Marr; K Seidel; T C White; R A Bowden
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

6.  Epidemiology of endemic Pseudomonas aeruginosa: why infection control efforts have failed.

Authors:  B Olson; R A Weinstein; C Nathan; W Chamberlin; S A Kabins
Journal:  J Infect Dis       Date:  1984-12       Impact factor: 5.226

7.  Hospital-acquired infections in intensive care unit patients: an overview with emphasis on epidemics.

Authors:  R P Wenzel; R L Thompson; S M Landry; B S Russell; P J Miller; S Ponce de Leon; G B Miller
Journal:  Infect Control       Date:  1983 Sep-Oct

8.  Neonatal respiratory syncytial virus infection.

Authors:  C B Hall; A E Kopelman; R G Douglas; J M Geiman; M P Meagher
Journal:  N Engl J Med       Date:  1979-02-22       Impact factor: 91.245

9.  The SENIC Project. Study on the efficacy of nosocomial infection control (SENIC Project). Summary of study design.

Authors:  R W Haley; D Quade; H E Freeman; J V Bennett
Journal:  Am J Epidemiol       Date:  1980-05       Impact factor: 4.897

10.  Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.

Authors:  R Viscidi; S Willey; J G Bartlett
Journal:  Gastroenterology       Date:  1981-07       Impact factor: 22.682

View more
  131 in total

1.  Influenza infection control guidance provided to staff at Veterans Affairs facilities for veterans with spinal cord injury during a pandemic(†).

Authors:  Sara M Locatelli; Sherri L Lavela; Timothy P Hogan; Barry Goldstein
Journal:  J Spinal Cord Med       Date:  2013-04-13       Impact factor: 1.985

2.  Microbiological burden in air culture at various units of a tertiary care government hospital in Nepal.

Authors:  Binaya Sapkota; Gopal Kumar Gupta; Saroj Kumar Shrestha; Ashish Pradhan; Prasant Karki; Ajit Thapa
Journal:  Australas Med J       Date:  2016-01-31

Review 3.  Antimicrobial hydrogels for the treatment of infection.

Authors:  Ana Salomé Veiga; Joel P Schneider
Journal:  Biopolymers       Date:  2013-11       Impact factor: 2.505

4.  Antigenic challenge in the etiology of autoimmune disease in women.

Authors:  Mary A M Rogers; Deborah A Levine; Neil Blumberg; Gwenith G Fisher; Mohammed Kabeto; Kenneth M Langa
Journal:  J Autoimmun       Date:  2011-08-30       Impact factor: 7.094

5.  Antimicrobial Resistance Surveillance among Intensive Care Units of a Tertiary Care Hospital in Southern India.

Authors:  Kailash Moolchandani; Apurba Sankar Sastry; R Deepashree; Sujatha Sistla; B N Harish; Jharna Mandal
Journal:  J Clin Diagn Res       Date:  2017-02-01

6.  Bacterial imaging and photodynamic inactivation using zinc(II)-dipicolylamine BODIPY conjugates.

Authors:  Douglas R Rice; Haiying Gan; Bradley D Smith
Journal:  Photochem Photobiol Sci       Date:  2015-07       Impact factor: 3.982

Review 7.  The rise of the Enterococcus: beyond vancomycin resistance.

Authors:  Cesar A Arias; Barbara E Murray
Journal:  Nat Rev Microbiol       Date:  2012-03-16       Impact factor: 60.633

Review 8.  Perioperative strategies to prevent surgical-site infection.

Authors:  Juan Lucas Poggio
Journal:  Clin Colon Rectal Surg       Date:  2013-09

Review 9.  Infection control for norovirus.

Authors:  L Barclay; G W Park; E Vega; A Hall; U Parashar; J Vinjé; B Lopman
Journal:  Clin Microbiol Infect       Date:  2014-07-16       Impact factor: 8.067

10.  Protection of mice against Staphylococcus aureus infection by a recombinant protein ClfA-IsdB-Hlg as a vaccine candidate.

Authors:  Somayeh Delfani; Ashraf Mohabati Mobarez; Abbas Ali Imani Fooladi; Jafar Amani; Mohammad Emaneini
Journal:  Med Microbiol Immunol       Date:  2015-07-09       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.